Having trouble accessing articles? Reset your cache.

Amgen beats Street

Amgen Inc. (NASDAQ:AMGN) reported 2Q10 adjusted diluted EPS of $1.38, beating by $0.08 the Street's estimate

Read the full 160 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE